Tudor Investment Corp
EIDX

Tudor Investment Corp’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Tudor Investment Corp’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-155,671
Closed -$20.5M – 1987
2020
Q4 		$20.5M Buy
+155,671
New +$13.8M 0.58% 19
2018
Q3 		– Sell
-10,000
Closed -$203K – 1337
2018
Q2 		$203K Buy
+10,000
New +$210K 0.01% 923

Tudor Investment Corp's EIDX Position: Q1 2021 in Review

Tudor Investment Corp sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 155,671 shares — an estimated $20.5M sold.

Tudor Investment Corp first reported a position in EIDX in Q2 2018 and held it in 2 quarters. The position peaked at $20.5M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • Tudor Investment Corp reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Tudor Investment Corp sold 155,671 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $20.5M.
  • Tudor Investment Corp first reported a position in Eidos Therapeutics, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • Tudor Investment Corp's Eidos Therapeutics, Inc. Common Stock position peaked at $20.5M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Tudor Investment Corp's 13F filing for Q1 2021, filed 17 May 2021.